>> “It does little to address the weakness in the Phase-3 pipeline and exhausts the company's cash pile for share buybacks and product acquisitions,” Merrill Lynch analysts wrote in a research note. <<
Here’s a simpler argument: AZN is simply paying too much.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.